Hitachi Medical warns of first-half loss

Article

Hitachi Medical expects to report a net loss of $5.67 million for the half-year ended Sept. 30. The company said that despite strong U.S. sales of MRI and diagnostic ultrasound systems, CT and ultrasound sales in Japan have been weak. Hitachi had

Hitachi Medical expects to report a net loss of $5.67 million for the half-year ended Sept. 30. The company said that despite strong U.S. sales of MRI and diagnostic ultrasound systems, CT and ultrasound sales in Japan have been weak.

Hitachi had projected a profit of $3.02 million for the period. The firm said group sales would likely reach $451 million, some $54.44 million short of the original projection.

A spokesperson for the Hitachi Medical Corporation of America said the ultrasound division in the U.S. had exceeded its sales goals in the past few months. She said the company plans new product introductions at the RSNA show.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.